COVID-19
FDA Panel Suggests Redesigning Vaccines to Target Omicron Variants, Pfizer & Sanofi Share Booster Updates
2022-06-29
FDA Rejects Emergency Use Authorization for Common and Inexpensive Antidepressant COVID-19 Treatment
2022-05-20